| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |